{"filing":{"accession_number":"0001493152-26-033393","cik":"0001506983","ticker":"GCTK","company_name":"Glucotrack, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226033393/form8-k.htm"},"events":[{"id":18219,"run_id":16370,"accession_number":"0001493152-26-033393","anchor_item_number":"8.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"The Item 8.01 disclosure describes the completion of a strategic business combination between Glucotrack, Inc. and Lōkahi Therapeutics, with Lōkahi becoming the operating and controlling business of the combined company. The press release (Exhibit 99.1) explicitly states \"Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination\" and references an Agreement and Plan of Merger dated July 14, 2026 (Exhibit 2.1). This is a material acquisition/change of control transaction that fundamentally restructures the company's ownership and operations.","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16963,"accession_number":"0001493152-26-033393","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The Item 8.01 disclosure describes the completion of a strategic business combination between Glucotrack, Inc. and Lōkahi Therapeutics, with Lōkahi becoming the operating and controlling business of the combined company. The press release (Exhibit 99.1) explicitly states \"Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination\" and references an Agreement and Plan of Merger dated July 14, 2026 (Exhibit 2.1). This is a material acquisition/change of control transaction that fundamentally restructures the company's ownership and operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:21:37.537691+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16963,"accession_number":"0001493152-26-033393","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The Item 8.01 disclosure describes the completion of a strategic business combination between Glucotrack, Inc. and Lōkahi Therapeutics, with Lōkahi becoming the operating and controlling business of the combined company. The press release (Exhibit 99.1) explicitly states \"Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination\" and references an Agreement and Plan of Merger dated July 14, 2026 (Exhibit 2.1). This is a material acquisition/change of control transaction that fundamentally restructures the company's ownership and operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:21:37.537691+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-07-15"}]}